[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341196-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341196-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","xist-and-muc1-c-form-an-auto-regulatory-pathway-in-driving-cancer-progression","XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression","","Long non-coding RNA XIST and the MUC1 gene are dysregulated in chronic inflammation and cancer, yet their functional relationship was unclear. This study shows that MUC1-C modulates XIST lncRNA levels by suppressing RBM15/B, WTAP and METTL3/14 m6A methylation components and the YTHDF2-CNOT1 deadenylase complex, increasing XIST stability and expression. XIST reciprocally enhances MUC1-C through NF-κB-mediated activation of the MUC1 gene.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/xist-and-muc1-c-form-an-auto-regulatory-pathway-in-driving-cancer-progression/341196/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/xist-and-muc1-c-form-an-auto-regulatory-pathway-in-driving-cancer-progression/341196.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does MUC1-C regulate XIST lncRNA levels?","Question",{"text":63,"@type":64},"MUC1-C suppresses m6A methylation complex components associated with XIST A repeats and inhibits the YTHDF2-CNOT1 deadenylase complex that recognizes m6A sites, which increases XIST stability and expression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does XIST regulate MUC1-C expression?",{"text":68,"@type":64},"XIST promotes NF-κB-mediated activation of the MUC1 gene, thereby regulating MUC1-C expression and supporting an auto-regulatory pathway.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the significance of the MUC1-C/XIST pathway in cancer?",{"text":72,"@type":64},"The pathway regulates common inflammation and stemness-associated genes, including miR-21 and TDP-43, and is reported to drive stemness-associated genes and be necessary for self-renewal capacity, impacting cancer progression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341196,1790731669,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nXIST and MUC1-C form an auto-regulatory pathway in driving cancer progression  \nKeyi Wang 1,3, Atrayee Bhattacharya1,3, Naoki Haratake 1, Tatsuaki Daimon 1, Ayako Nakashoji 1, Hiroki Ozawa 1, Bo Peng2, Wei Li2 ✉ and Donald Kufe 1 ✉  \n© The Author(s) 2024  \n\n|  | The long non-coding RNA X-inactive speciﬁc transcript (lncRNA XIST) and MUC1 gene are dysregulated in chronic inﬂammation and cancer; however, there is no known interaction of their functions. The present studies demonstrate that MUC1-C regulates XIST lncRNA levels by suppressing the RBM15/B, WTAP and METTL3/14 components of the m6A methylation complex that associate with XIST A repeats. MUC1-C also suppresses the YTHDF2-CNOT1 deadenylase complex that recognizes m6A sites and contributes to XIST decay with increases in XIST stability and expression. In support of an auto-regulatory pathway, we show that XIST regulates MUC1-C expression by promoting NF-κB-mediated activation of the MUC1 gene. Of signiﬁcance, MUC1-C and XIST regulate common genes associated with inﬂammation and stemness, including (i) miR-21 which is upregulated across pan-cancers, and (ii) TDP-43 which associates with the XIST E repeats. Our results further demonstrate that the MUC1-C/XIST pathway (i) is regulated by TDP-43,(ii) drives stemness-associated genes, and (iii) is necessary for self-renewal capacity. These ﬁndings indicate that the MUC1- |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| C/XIST auto-regulatory axis is of importance in cancer progression. |  |  |\n|  | Cell Death and Disease (2024)15:330; [https://doi.org/10.1038/s41419-024-06684-9](https://doi.org/10.1038/s41419-024-06684-9) |  |\n|  |  |  |\n\nINTRODUCTION  \nThe lncRNA XIST initiates X chromosome inactivation (XCI) in female placental mammals to balance dosage of X-linked gene expression between the sexes [1] . In executing phases of XCI, repeat arrays in the XIST RNA interact with diverse effectors that include the m6A methylation complex, epigenetic modiﬁers, and RNA splicing factors [2] . In addition to initiating and executing XCI, XIST plays a role in the inﬂammatory response of post-XCI somatic cells. XIST responds to acute inﬂammation by regulating NF-κB activity [3, 4] . XIST is also dysregulated in settings of chronic inﬂammation, including atherosclerosis [5] and neurodegenerative diseases [6] . Dysregulation of XIST expression has been recognized across numerous female and male cancers in association with both tumor progression and suppression [7–9] . Studies in breast cancer cells have implicated XIST overexpression with loss of the inactive X chromosome (Xi) or Barr body and increased transcription of the active X chromosome [10–12] . Other work has indicated that the XCI transcriptional program can be selectively accessed in male cancers [13] . Aberrant overexpression of XIST in cancer largely functions in promoting oncogenesis by regulating inﬂammation and diverse miRNAs that contribute to the CSC state and drug resistance [9, 14, 15] . In contrast to studies of XCI, less is known about the regulation of XIST, the effectors that bind to the XISTarray repeats and downstream target genes in cancer cells. The potential involvement of XIST in contributing to intrinsic  \nchronic inﬂammation in cancer progression also remains unclear.  \nThe MUC1 gene evolved in mammals for the protection of barrier tissues from loss of homeostasis [16–18]. MUC1 encodes atransmembrane MUC1-C subunit that is activated by inﬂammation and contributes to barrier tissue stem cell functions associated with wound healing [17, 18]. MUC1-C induces lineage plasticity, the epithelial-mesenchymal transition (EMT), epigenetic reprogramming, and chromatin remodeling, which are of importance for repair and memory responses to inﬂammation [17–20]. These responses are in principle reversible with repair; however, persistent MUC1-","cbCaitMFHlgR2vyW","https://ap.wps.com/l/cbCaitMFHlgR2vyW","pdf",4315466,12,"English","# Introduction\n## XIST in inflammation and cancer\n## MUC1-C function in chronic inflammation and cancer stemness\n# Results\n## Targeting MUC1-C suppresses XIST expression","[{\"question\":\"How does MUC1-C regulate XIST lncRNA levels?\",\"answer\":\"MUC1-C suppresses m6A methylation complex components associated with XIST A repeats and inhibits the YTHDF2-CNOT1 deadenylase complex that recognizes m6A sites, which increases XIST stability and expression.\"},{\"question\":\"How does XIST regulate MUC1-C expression?\",\"answer\":\"XIST promotes NF-κB-mediated activation of the MUC1 gene, thereby regulating MUC1-C expression and supporting an auto-regulatory pathway.\"},{\"question\":\"What is the significance of the MUC1-C/XIST pathway in cancer?\",\"answer\":\"The pathway regulates common inflammation and stemness-associated genes, including miR-21 and TDP-43, and is reported to drive stemness-associated genes and be necessary for self-renewal capacity, impacting cancer progression.\"}]","XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression | PDF",1790040853,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f131ba1934cbedd01317a09d8cd30197.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ae2136f06b9303f26c9d0fae8d89c76.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f781c3e7a79ee8003822400efe9e3e8.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d39ae9437f6debd3218468fb93fe6b27.webp",980,1301]